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Abstract
Introduction: The diagnosis of acute lung injury (ALI) may be more robust if more accurate physiological markers
can be identified. Extravascular lung water (EVLW) is one possible marker, and it has been shown to correlate with
respiratory function and mortality in patients with sepsis. Whether EVLW confers diagnostic value in a general
population with shock, as well as which index performs best, is unclear. We investigated the diagnostic accuracy of
various EVLW indices in patients with shock.
Methods: We studied a prospective, observational cohort of 51 patients with shock admitted to a tertiary ICU.
EVLW was measured within 6 hours of ICU admission and indexed to actual body weight (EVLW/ABW), predicted
body weight (EVLW/PBW) and pulmonary blood volume (EVLW/PBV). The relationship of these indices to the
diagnosis and severity of lung injury and ICU mortality were studied. Positive and negative likelihood ratios, pre-
and posttest odds for diagnosis of lung injury and mortality were calculated.
Results: All EVLW indices were higher among patients with lung injury and significantly correlated with respiratory
parameters. Furthermore, all EVLW indices were significantly higher in nonsurvivors. The use of EVLW improves the
posttest OR for the diagnosis of ALI, acute respiratory distress syndrome (ARDS) and severe lung injury (sLI) by up
to eightfold. Combining increased EVLW and a diagnosis of ALI, ARDS or sLI increases the posttest odds of ICU
mortality. EVLW/ABW and EVLW/PBV demonstrated the best diagnostic performance in this population.
Conclusions: EVLW was associated with degree of lung injury and mortality, regardless of the index used,
confirming that it may be used as a bedside indicator of disease severity. The use of EVLW as a bedside test
conferred added diagnostic value for the identification of patients with lung injury.
Keywords: acute respiratory distress syndrome, acute lung injury, extravascular lung water, sepsis, shock, pulmon-
ary oedema, likelihood ratio
Introduction
Extravascular lung water (EVLW) is an estimation of the
fluid in the pulmonary interstitial and alveolar spaces
[1]. In ICUs, EVLW is usually obtained as one of the
parameters in the PiCCO monitor (PiCCO plus; PUL-
SION Medical Systems, Munich, Germany) by using a
transpulmonary thermodilution technique. EVLW may
be used as a bedside indicator of extravascular leakage,
such as in a patient with acute lung injury (ALI) [1-7],
although this requires further confirmation.
The present study was driven by current limitations in
the diagnosis and prognosis of ALI and ARDS. For
example, the North American-European Consensus
Conference (NAECC) criteria may be too insensitive for
identifying ‘subclinical ARDS’. Conversely, their specifi-
city has also been questioned because some patients
identified by these criteria no longer fulfil the criteria
for ARDS after 24 hours on mechanical ventilation [8].
Furthermore, it is known that the Lung Injury Score
(LIS) and the ratio of partial pressure of oxygen in
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arterial blood to the fraction of inspired oxygen (PaO2/
FiO2) lack sensitivity for predicting mortality [9],
although they are clearly indicative of lung injury. It has
been proposed that the diagnosis and prognosis of lung
injury may be more robust if more accurate physiologi-
cal markers can be identified. EVLW has been proposed
as one such method [10-12], and there are a number of
studies attesting to the value of EVLW for clinical out-
come prediction [2,4,5,13-17].
In previous studies, EVLW has been investigated
mainly within the context of sepsis and septic shock,
and it seems to be associated with the severity of
respiratory dysfunction and mortality [2,4,5,7,15-17].
However, ALI and ARDS may also occur in patients
without sepsis. Thus it is relevant to study EVLW in lar-
ger populations at high risk of developing the disease.
These populations would encompass critically ill
patients with systemic inflammation due to any cause
(septic and nonseptic) and shock. It is also unclear
which EVLW index is the most useful measure. Most
reports regarding EVLW have used an index based on
actual body weight (ABW). Three recent studies indicate
that using predicted body weight (PBW) may be a better
predictor of survival and disease severity [2-4]. Indexing
EVLW to PBW instead of to ABW has been shown to
improve the correlation between EVLW and LIS and
the PaO2/FiO2 ratio [3]. EVLW indexed to pulmonary
blood volume (PBV) is another measure and is thought
to reflect increased hydrostatic pressure and pulmonary
permeability [5-7,18]. It has been proposed as a useful
index for differentiating the two mechanisms of
increased EVLW [18].
These considerations led us to ask the following ques-
tions about critically ill patients with shock who are at
risk for developing lung injury. (1) How well do differ-
ent EVLW indices measure the severity of lung injury?
(2) How well do the different EVLW indices relate to
ICU mortality? (3) By applying EVLW as a bedside test,
can the chances of diagnosing lung injury be increased?
We investigated various indices of EVLW in relation to
the presence and severity of lung injury and ICU mor-
tality. Finally, we investigated the diagnostic value of the
various indices for ALI, ARDS and severe lung injury
(sLI) as defined by the NAECC criteria and LIS,
respectively.
Materials and methods
The present study was approved by the Regional Ethical
Review Board, Lund, Sweden (Dnr.187/2005). Informed
consent was sought either from the patient or, if not
possible, from the patient’s next of kin. The study design
comprised a single-centre, prospective observational
cohort of critically ill patients admitted to the mixed-
bed ICU of Skåne University Hospital, Malmö, Sweden.
Fifty-five consecutive patients with the systemic inflam-
matory response syndrome (SIRS) and shock despite
fluid resuscitation were included. Specifically, patients
were older than 18 years of age who met the SIRS cri-
teria [19] and exhibited ‘circulatory failure’, defined as
the failure to maintain mean arterial pressure ≥70
mmHg despite adequate fluid resuscitation according to
the Surviving Sepsis Campaign algorithm [20]. Exclusion
criteria were pregnancy, abnormalities of coagulation,
fibrinolytic therapy, compromised immunity or a Do
Not Attempt Resuscitation order. Patients could be
included only once.
’Sepsis’ was defined according to the criteria published
by Bernard et al. [21]. ALI and ARDS were defined by
the criteria set forth by the NAECC [22]. sLI was
defined using the LIS proposed by Murray et al. [23],
with sLI indicated by a score > 2.5. Acute Physiology
and Chronic Health Evaluation II (APACHE II) scores
[24] were calculated at admission, and Sequential Organ
Failure Assessment scores [25] were calculated on each
day of the study period. Ventilator settings (Evita XL
ventilator; Dräger, Lübeck, Germany), including positive
end-expiratory pressure (PEEP) and FiO2, were
recorded, and if the patient was not mechanically venti-
lated, FiO2 was obtained from conversion according to
commonly used tables [26]. An arterial blood sample
was obtained every 6 hours. A bedside chest X-ray
(CXR) was obtained at the time of inclusion and there-
after at the treating physician’s discretion. X-rays were
analysed for quadrants of alveolar consolidation (CXR
score) as part of the LIS calculation [23].
All patients were initially treated according to interna-
tional guidelines for the management of sepsis and sep-
tic shock [20]. This set of guidelines was applied to all
patients at study inclusion because we were not able to
identify at the outset all patients with sepsis. After the
initial resuscitation period, fluids were given at the treat-
ing clinician’s discretion. Regardless of shock aetiology,
ventilator settings were set at 6 to 8 ml/kg PBW. Per-
missive hypercapnia was accepted. PEEP was adjusted to
maximise compliance and oxygenation using a decre-
mental PEEP trial. Recruitment was performed at the
clinician’s discretion. Patients were monitored according
to standard ICU routines but also were treated with a 5-
French femoral artery catheter (PV2015L20N; PULSION
Medical Systems, Munich, Germany) and, if not already
existing, a central venous catheter inserted into the
internal jugular or subclavian vein.
PiCCO calibration and analysis were performed within
6 hours of study inclusion using mean values from three
20-ml iced saline injections. The method is based on
measurement of temperature change over time in the
femoral catheter after injection of cold saline solution
into the central venous catheter. The transpulmonary
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thermodilution curve obtained is then analysed to calcu-
late the cardiac output using the Stewart-Hamilton algo-
rithm. Intrathoracic thermal volume and the pulmonary
thermal volume are derived from the mean transit time
and the exponential downslope time of the thermodilu-
tion curve. On the basis of these data, volumetric vari-
ables, including EVLW, may be estimated; their
derivation has been described in detail previously
[1,14-16]. Measurements taken within the first 6 hours
of study inclusion made up the data set for this study.
EVLW was indexed to ABW, PBW and PBV. PBW
(kg) was calculated as 50 + 0.91 for males (height =
152.4 cm) and 45.5 + 0.91 for females (height = 152.4
cm). We studied these EVLW indices within 6 hours of
study inclusion. The relationship between EVLW indices
and respiratory parameters (presence of ALI and ARDS,
sLI, PaO2/FiO2, CXR score and PEEP) to ICU mortality
were examined.
Statistical analysis
Sample size was powered to detect a minimum differ-
ence between survivors and nonsurvivors of 2 ml/kg
EVLW with a 2 ml/kg standard deviation of residuals, a
= 0.05 and b = 0.8 using a t-test. These data gave us a
sample size of 17 patients; however, because we were
unsure of the variability of the data, and based on sam-
ple sizes in previous studies, we tripled our sample size.
Data are presented as medians [IQR]. For correlations
between two variables, Spearman’s rank-correlation test
was used; for differences between two groups, the
Mann-Whitney U test was used. For comparison of
multiple groups, analysis of variance on ranks was used
and a Bonferroni correction was applied. Testing of pro-
portions was carried out using Fisher’s exact test. Signif-
icance was set at P < 0.05. Normality was tested for
using the Kolmogorov-Smirnov test. The analyses were
performed using SPSS version 16.0 software (SPSS Inc,
Chicago, IL, USA) and SigmaStat version 3.5 for Win-
dows software (Systat Software, Inc, San Jose, CA, USA).
For the evaluation of the diagnostic accuracy of each
EVLW index, we calculated the positive likelihood ratio
(LR+) and negative likelihood ratio (LR-), where LR+ is
the sensitivity/(1 - specificity) and LR- is (1 - sensitiv-
ity)/specificity. The pretest odds of disease is given by
P/(1 - P), where P is the probability of the disease in the
current population. The posttest odds given a positive
test are the product of the LR+ and pretest odds,
whereas the posttest odds given a negative test is the
product of the LR- and the pretest odds.
Results
The original study included 55 consecutive patients.
Two were excluded because of their lack of consent.
Two other patients never received a femoral catheter
because of technical difficulties (one with morbid obe-
sity and one who had undergone massive aortofemoral
surgery) and were excluded from further analysis. The
remaining 51 patients presented no major technical dif-
ficulties and experienced no significant adverse events.
At the time of inclusion, we managed to obtain EVLW
data from 86% of the patients, and after 6 hours we had
taken at least one measurement from all included
patients. Thirty-four patients (67%) had septic shock
according to the predefined criteria [21]. The remaining
17 patients had shock due to other causes, including
pancreatitis (5 patients), post-noncardiac major surgery
(5 patients), intoxication and multiorgan failure (2
patients) and gastrointestinal bleeding and portal hyper-
tension (1 patient). In four patients, the cause of shock
and organ failure was never established, although sepsis
could not be ruled out. The patients’ characteristics and
clinical parameters are shown in Table 1.
Extravascular lung water index and respiratory function
Eighteen (35%) and fifteen (29%) of the fifty-one patients
fulfilled the NAECC criteria for ALI and ARDS, respec-
tively. In contrast, only nine patients (18%) patients




Age at time of inclusion (years) 66 [57 to 76]
BMI (kg/m2) 25.8 [23.4 to 28.9]
Proportion with sepsis (%) 67
ICU mortality (%) 29
6-month mortality (%) 37
Proportion with ALI (%)a 35
Proportion with ARDS (%)a 29
Proportion with sLI (%)b 18
APACHE II score 24 [19 to 29]
SOFA score 12 [9 to 14]
PaO2/FiO2 ratio 230 [160 to 290]
PEEP (mmHg) 7 [5 to 10]
Arterial blood lactate (mmol/L) 3.0 [1.9 to 4.5]
CI (L/min/m2) 3.5 [2.8 to 4.5]
ITBVI (ml/m2) 1,010 [840 to 1,200]
EVLW/PBW ratio (ml/kg) 9.7 [7.7 to 12.4]
EVLW/ABW ratio (ml/kg) 8.3 [6.3 to 10.6]
EVLW/PBV ratio 1.8 [1.4 to 2.2]
ABW: actual body weight; ALI: acute lung injury; APACHE II: Acute Physiology
and Chronic Health Evaluation II; ARDS: acute respiratory distress syndrome;
BMI: body mass index; CI: cardiac index; EVLW: extravascular lung water; FiO2:
fraction of inspired oxygen; ITBVI: intrathoracic blood volume index; PaO2:
partial pressure of oxygen in arterial blood; PBV: pulmonary blood volume;
PBW: predicted body weight; PEEP: positive end-expiratory pressure; sLI:
severe lung injury; SOFA: Sequential Organ Failure Assessment. aDefined by
the NAECC [22]; bdefined by Murray’s Lung Injury Score [23]. Data are
medians [IQR].
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fulfilled the criteria for sLI according to Murray’s LIS.
The different EVLW indices were modestly correlated
with PaO2/FiO2 (r = -0.371 to -0.487, P = 0.001 to
0.007) and CXR score (r = 0.255 to 0.455, P = 0.002 to
0.09), but not with PEEP.
Patients with increased EVLW indexed to body weight
[> 10 ml/kg] had significantly lower oxygenation than
those with normal EVLW. For EVLW/ABW, the data
were 149 [111 to 234] vs 246 [192 to 301], P = 0.006;
and for EVLW/PBW, the data were 158 [121 to 241] vs
256 [198 to 302], P = 0.004. Similar results were
obtained for EVLW/PBV: 193 [143 to 282] vs 270 [220
to 289], P = 0.03. EVLW indexed to ABW and PBW
were significantly higher in patients with ALI and ARDS
(Figures 1a and 1b). EVLW indexed to PBV was also
higher in these patients (Figures 2a and 2b). There were
significant incremental increases in EVLW indices with
each increasing stratum of the LIS score (Figure 3).
Extravascular lung water and mortality
All three EVLW indices were significantly higher in
nonsurvivors vs nonsurvivors, respectively: EVLW/ABW
7.4 [5.9 to 9.4] vs 9.1 [7.9 to 12.9], P = 0.02; EVLW/
PBW 9.1 [7.2 to 11.6] vs 10.6 [9.5 to 13.0], P = 0.05;
EVLW/PBV 1.6 [1.3 to 2.0] vs 2.0 [1.6 to 2.6], P = 0.03
(Figure 4). The corresponding LR+ and LR- as well as
pre- and posttest odds of death given a positive EVLW
test are shown in Table 2.
Diagnostic value of extravascular lung water
Depending on which index was used, EVLW identified
between 44% and 100% of all patients with sLI (LIS >
2.5), 27% to 33% of those with ALI and 33% to 38% of
those with ARDS. The sensitivities, specificities, LR+
and LR- and pre- and posttest odds for making a diag-
nosis of ALI, ARDS or sLI using various EVLW indices
are shown in Table 3. By applying EVLW measurement
as a bedside test, the posttest OR for the diagnosis of
ALI and ARDS increased more than threefold when
EVLW/ABW was used (from 0.55 to 1.8 for ALI, from
0.42 to 1.33 for ARDS). When using the same index, the
posttest OR for sLI increased twofold.
In comparison, using EVLW/PBV as a bedside test
increased the posttest OR for ALI and ARDS by 1.8 and
1.6 times, respectively, whereas the posttest OR for sLI
increased more than eightfold. The posttest OR for lung
injury by any definition decreased markedly given a
negative EVLW test.
Discussion
Our main finding is that increased EVLW adds diagnos-
tic value in identifying patients with lung injury.
Furthermore, it was significantly associated with disease
severity and mortality. These findings support previous
studies in which EVLW was found to be useful in char-
acterising the severity of respiratory disease in patients
with sepsis and those with ARDS [2-5,15-18,27]. We
have shown in the present study that measurement of
EVLW early during ICU admission in a wider popula-
tion of critically ill patients at risk of developing lung
injury is of both diagnostic and clinical significance.
This was seen for all EVLW indices.
As a bedside test, EVLW/PBV provided excellent diag-
nostic accuracy for identifying patients with sLI accord-
ing to Murray’s LIS. For the diagnosis of ALI and
ARDS, EVLW/ABW performed best as demonstrated by
higher LR+. The application of increased EVLW as a
bedside test improved the diagnostic accuracy for ALI,
ARDS and sLI with two- to eightfold increases in the
posttest OR observed in this population. Importantly, a
negative EVLW test markedly decreases the OR of lung
injury diagnosis, thus helping to rule out disease [28].
’Ruling in’ disease may not translate to real clinical
outcomes, hence there is a need to further assess the
utility of EVLW in these terms. The present study
shows not only that EVLW measured early during ICU
admission may be used as a marker of respiratory dys-
function in patients with shock but also that EVLW is
increased in nonsurvivors. This is consistent with earlier
studies of patients with sepsis and ARDS [2-5,15-18]
and extends current knowledge by showing that the
posttest OR for mortality increases when EVLW is used
as a diagnostic test, making this test clinically relevant.
This is particularly true when combined with a prior
diagnosis of ALI, ARDS or sLI, where the odds of mor-
tality increase even further. The clear relationship
between EVLW and several indicators of respiratory
function, as well as the mortality seen in this study, sup-
port the utility of this bedside index for improved diag-
nosis and risk stratification early during ICU admission.
Theoretically, PBW seems to be a more logical index
than ABW because lung volume does not increase with
body fat. Because many critically ill patients are overweight
[29], EVLW/PBW should be a better index. Although we
found significant correlations between EVLW/PBW and
respiratory function, EVLW/PBW demonstrated a weaker
statistical relationship to mortality than EVLW/ABW or
PBV. These results are in contrast to previous findings
that indexing with PBW improved disease characterisation
and correlations with survival [2-4]. One explanation for
this discrepancy is that our patient population was not
grossly overweight, with a median body mass index (BMI)
of 25.8 kg/m2. Furthermore, there were significant differ-
ences in BMI between survivors and nonsurvivors, with
the latter having lower BMI values, hence confounding
any possible effect of adjustment for overweight. This
study was conducted in a heterogeneous population at risk
for developing lung injury, whereas researchers in previous
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studies investigated populations with established ARDS
[2-4].
Another potentially attractive index to use is EVLW/
PBV [6,7,18]. This index differs from EVLW adjusted
for body weight in that it is thought to reflect
increased lung water due to excessive hydrostatic pres-
sure and vascular permeability independently of fluid
status [6,7]. A recent study suggested that EVLW/PBV
        a) ALI  
 
       b) ARDS    
Figure 1 Extravascular lung water indexed to actual and predicted body weight in patients with or without acute lung injury and/or
acute respiratory distress syndrome. (a) Extravascular lung water (EVLW) indexed to actual body weight (ABW) and predicted body weight
(PBW) in patients with or without acute lung injury (ALI). Filled boxes = patients with ALI, unfilled boxes = patients without ALI (ABW: 10.4 [7.4
to 16.7] vs 7.8 [5.9 to 9.6], P = 0.01; PBW: 12.4 [9.4 to 17.7] vs 8.2 [7.5 to 10.9], P = 0.01). (b) EVLW indexed to ABW and PBW in patients with or
without ARDS. Filled boxes = patients with ARDS, unfilled boxes = patients without ARDS (ABW: 10.0 [8.4 to 16.7] vs 7.8 [5.9 to 9.6], P = 0.01;
PBW: 12.4 [9.4 to 17.7] vs 8.3 [7.5 to 10.9], P = 0.01). Data are medians [IQR]. *P < 0.05.
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may even be useful for differentiating hydrostatic and
pulmonary permeability mechanisms of increased
EVLW [18]. EVLW/PBV consistently produced the
lowest LR- compared to the other indices, reinforcing
its usefulness in ruling out disease [28]. When mea-
sured against the ‘gold standard’ of sLI using Murray’s
LIS, EVLW/PBV performed well as a diagnostic test,




Figure 2 Extravascular lung water indexed to pulmonary blood
volume in patients with or without acute lung injury and/or
acute respiratory distress syndrome. (a) Extravascular lung water
(EVLW) indexed to pulmonary blood volume (PBV) in patients with
or without acute lung injury (ALI). Filled boxes = patients with ALI,
unfilled boxes = patients without ALI (PBV: 2.1 [1.6 to 3.0] vs 1.6 [1.3
to 1.9], P = 0.02). (b) EVLW indexed to PBV in patients with or
without acute respiratory distress syndrome (ARDS). Filled boxes =
patients with ARDS, unfilled boxes = patients without ARDS (2.3 [1.6
to 3.1] vs 1.7 [1.3 to 1.9], P = 0.04). Data are medians [IQR]. *P <
0.05.
Figure 3 Boxplots for extravascular lung water stratified by
Lung Injury Score. *P < 0.05 and **P < 0.01. Because there were
only two patients in the group with Lung Injury Score (LIS) > 3, the
group was omitted from statistical analyses and data are not shown.
ABW: actual body weight; EVLW: extravascular lung water; PBV:
pulmonary blood volume; PBW: predicted body weight.
Chew et al. Critical Care 2012, 16:R1
http://ccforum.com/content/16/1/R1
Page 6 of 9
posttest odds of mortality, EVLW/PBV did not per-
form better than EVLW/ABW.
How may these results be applied clinically? First, we
believe that EVLW may be used as an adjunct in the
characterisation of sLI. There has been much debate
regarding the usefulness of the NAECC criteria and the
lack of specificity of LIS and PaO2/FiO2 in predicting
mortality, leading to a search for more ‘objective’ criteria
for ARDS [11] and for assessing the severity of lung
injury [8]. Although the present study is not the first to
report a relationship between EVLW and mortality, we
have shown by calculating the LR+ and posttest odds
[28] that increased EVLW confers additional diagnostic
value for the identification of patients with lung injury
and raises the odds for mortality, thus supporting its
clinical relevance. This is particularly true when com-
bined with a diagnosis of ALI, ARDS or sLI. This rela-
tionship was present at an early stage (within 6 hours of
study inclusion) and was the first to document a step-
wise relationship with deteriorating lung function. Our
study also shows that the findings regarding increased
EVLW applies to a population with shock and not only
in patients with confirmed sepsis and/or ARDS. Early
and correct identification of sLI patients at high risk of
death allows the application of different treatment stra-
tegies and facilitates the design of clinical trials based on
more robust criteria, issues previously identified as
important for future research [8].
Our study has a number of limitations. Because of its
design, this study cannot definitively answer the ques-
tion whether EVLW is a better diagnostic test than the
NAECC and LIS criteria, because EVLW would have to
be compared to a gold standard which does not, at pre-
sent, exist. Although power calculations were based on
previously available data, our sample size was relatively
small. A larger study would have allowed us to conduct
multivariate regression analysis to establish whether
EVLW is an independent risk factor for mortality as
described by Craig et al. [4]. Although we used a prag-
matic definition of ‘sepsis’ [21], we cannot exclude that
some of the patients in the non-septic shock group also
in fact had sepsis. Furthermore, this group represents
only a limited proportion of the study population and a
larger number of patients may have influenced the
results. The study was not designed to investigate possi-
ble pathophysiological differences between EVLW/PBV
and EVLW indexed to body weight. There is a mathe-
matical coupling between intrathoracic thermal and
blood volumes on which EVLW calculation is depen-
dent. These and unaccounted for heterogeneous changes
in ventilation and perfusion may have influenced the
 
 
Figure 4 Extravascular lung water and mortality. Filled bars =
nonsurvivors, unfilled bars = survivors. *P < 0.05. ABW: actual body
weight; EVLW: extravascular lung water; PBV: pulmonary blood
volume; PBW: predicted body weight.
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results. We sought only to generate hypotheses in this
prospective, observational study; therefore, we cannot
provide mechanistic explanations regarding EVLW and
its relationship to clinical outcomes. Studies evaluating
the incremental value of adding EVLW to current diag-
nostic criteria for the prognosis of clinical outcomes
would be a logical next step in future research.
Conclusions
In this study of critically ill patients with systemic inflam-
mation and shock, EVLW measured early during the
course of disease was correlated with respiratory func-
tion. Using EVLW as a bedside test conferred added
diagnostic value for the identification of patients with
lung injury. Furthermore, increased EVLW was related to
severity of lung disease and mortality, confirming the
results of previous studies in patients with ALI/ARDS
and sepsis. Combining increased EVLW and a diagnosis
of ALI, ARDS or sLI increases the posttest odds of ICU
mortality. EVLW/ABW and PBV demonstrated the best
diagnostic performance in this population. Prospective
studies evaluating the value of adding EVLW to current
diagnostic criteria for the prognosis of clinical outcome
in at-risk populations and as a basis for tailored interven-
tions are logical proposals for future research.
Key messages
◆ EVLW is significantly related to the severity of
lung injury and mortality in patients with shock,
regardless of which index is used.
◆ Increased EVLW provides additional diagnostic
value for lung injury.
◆ Increased EVLW increases the odds of mortality,
especially when combined with a diagnosis of ALI,
ARDS and sLI.
◆ EVLW indexed to ABW and PBV provides the
best diagnostic and prognostic information in this
patient population.
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Table 2 Positive and negative likelihood ratios and pre- and posttest odds for mortality, given a positive
extravascular lung water test



















EVLW/ABW 1.83 0.55 0.38 0.69 2.27 0.70 0.38 0.86 1.89 0.79 0.38 0.71 4.40 0.70 0.38 1.66
EVLW/PBW 1.41 0.72 0.38 0.53 1.51 0.88 0.38 0.57 1.76 0.85 0.38 0.67 1.98 0.88 0.38 0.75
EVLW/PBV 2.11 0.59 0.38 0.80 1.76 0.85 0.38 0.67 2.11 0.86 0.38 0.80 3.52 0.78 0.38 1.33
ABW: actual body weight; ALI: acute lung injury; ARDS: acute respiratory distress syndrome; EVLW: extravascular lung water; LR-: negative likelihood ratio; LR+:
positive likelihood ratio; PBV: pulmonary blood volume; PBW: predicted body weight; sLI: severe lung injury. A positive EVLW test was defined as EVLW/ABW ratio
> 10 ml/kg, EVLW/PBW ratio > 10 ml/kg and EVLW/PBV ratio > 1.5.
Table 3 Sensitivity, specificity and positive and negative
likelihood ratios of EVLW/ABW, EVLW/PBW and EVLW/
PBV for diagnosis of acute lung injury, acute respiratory
distress syndrome or severe lung injury
EVLW index ALI ARDS sLI
EVLW/ABW
Sensitivity 0.50 0.53 0.44
Specificity 0.85 0.83 0.76
LR+ 3.30 3.2 1.87
LR- 0.60 0.56 0.73
Pretest odds 0.55 0.42 0.21
Posttest odds + 1.80 1.33 0.40
Posttest odds - 0.32 0.23 0.16
EVLW/PBW
Sensitivity 0.61 0.60 0.67
Specificity 0.70 0.67 0.81
LR+ 2.02 1.80 3.50
LR- 0.56 0.60 0.41
Pretest odds 0.56 0.42 0.21
Posttest odds + 1.10 0.75 0.75
Posttest odds - 0.30 0.25 0.09
EVLW/PBV
Sensitivity 0.89 0.87 1.0
Specificity 0.52 0.47 0.88
LR+ 1.83 1.64 8.4
LR- 0.22 0.28 0
Pretest odds 0.55 0.42 0.21
Posttest odds + 1.00 0.68 1.79
Posttest odds - 0.12 0.12 0
ABW: actual body weight; ALI: acute lung injury; ARDS: acute respiratory
distress syndrome; EVLW: extravascular lung water; LR-: negative likelihood
ratio; LR+: positive likelihood ratio; PBV: pulmonary blood volume; PBW:
predicted body weight; sLI: severe lung injury. Posttest odds given a positive
(posttest odds +) or negative EVLW test (posttest odds -) are also shown.
Positive EVLW tests were defined as EVLW/ABW > 10 ml/kg, EVLW/PBW > 10
ml/kg and EVLW/PBV > 1.5.
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